Interference of Iodinated Contrast Media in Serum Capillary Zone Electrophoresis
To the Editor: Automated capillary zone electrophoresis (e.g., on the Paragon 2000 CZE, Beckman Instruments) is an alternative to conventional electrophoretic methods for the separation of serum proteins (1) (2) (3) . The technique uses ultraviolet (UV) detection at 214 nm for direct quantification of peptide bonds, whereas conventional methods detect the protein fractions by staining with various reagents.
CZE has the advantage of improved precision and a faster turnaround (4 ) . Recent reports indicate, however, that the Paragon CZE 2000 masks deficiencies of ␣ 1 -antitrypsin (5 ) and that some radio-opaque agents simulate a monoclonal component in the ␣ 2 -globulin fraction in the CZE electropherogram (6, 7 ) .
We encountered an interference from the contrast medium Omnitrast ® , which produced an unexpected peak in the ␣ 2 -zone of the CZE electropherogram. We have now investigated the effect of 12 iodinated radio-opaque media (commercially available in Spain) on instrumentation (Paragon CZE 2000) operated as described by Bossuyt et al. (6 ) . When we used the desalting method described by Blessum et al. (7 ) to remove the observed interferences (see below), we found undesirable obstruction in Paragon system capillaries. Therefore, we investigated alternative desalting procedures.
The studied contrast media were Bilisegrol ® , Gastrografin Table 1 . The addition of each opaque medium (11 L of medium to 1 mL of serum) to a control serum to reach the expected concentration after bolus injection for radiographic examination (7.5 g/L) led to the appearance of an abnormal peak in the CZE. Such induced peaks had the same shapes and locations as the extra peaks found in the electropherograms of patients who were infused with contrast agents. The interference peak in the electropherograms was located at the prealbumin zone for meglumine iotroxate, at the anodal site of the ␣ 2 -globulin fraction for meglumine amidotrizoate, in the middle of the ␣ 2 -globulin fraction for ioxitalamic acid and iobitridol, at the cathodal site of the ␣ 2 -globulin fraction for iohexol, at the anodal site of the ␤-globulin fraction for sodiummeglumine ioxaglate, and in the middle of the ␤-globulin fraction for ioversol. In each of these cases, no peak was discerned on agarose electrophoresis (Paragon SPE kit; Beckman).
The interference caused by these low-molecular weight agents was removed by addition of activated charcoal (0.2 g to 1 mL of serum) to serum, agitation of the mixture in a vortex-mixer for 20 s, and subsequent centrifugation at 2000g for 5-10 min at 25°C. Serum was carefully recovered without removing the charcoal residues from the bottom and walls of the tube. In some cases, a second or a third centrifugation stage was necessary to achieve complete clarity of serum. This procedure was completely useful, fast, and simple for all samples.
Bossuyt et al. (6 ) suggested (with data not shown) that this interference is attributable to the absorbance at 214 nm of both resolved proteins and iodinated contrast media. UV spectral data (obtained with a 550 UV-Vis Perkin-Elmer spectrophotometer) showed that the iodinated contrast agents absorbed light in the far UV but with maxima between 237 and 244 nm in either physiological media or CZE buffer at pH 10. The locations of the interfering peaks in the electropherogram became increasingly cathodal with increasing wavelengths of UV absorbance maxima of the radioopaque media (Table 1) . After treatment of the contrast media with the signal reagent (which, according to a personal communication from the manufacturer, contains at least two different peptides), shifts of the UV absorbance maxima at ϳ270 nm were observed; however, if the process was repeated with a mixture of the signal reagent and the borate buffer reagent (pH 10) with adequate dilution, the final absorbance was decreased at the wavelength at which detection occurs (208 -220 nm). These experimental findings gave evidence of actual bind- ing of the radio-opaque agents to peptides. Therefore, we must reasonably wonder if the appearance of interfering peaks in the electropherograms is only a coincidence of the unexpected elution times and absorbance spectra of the iodinated radio-opaque media with the stated elution times and absorbance spectra of the proteins (6 ) or a result of binding to the signal reagent.
We conclude that blood must not be collected for protein electrophoresis by CZE from patients who have received contrast media during the preceding 2-6 days. This time period has been described for some radioopaque agents by Bossuyt et al. (6 ) and should be established for new contrast media according to their elimination times from blood. In addition, in questionable samples for paraprotein with negative immunofixation, we recommend the desalting procedure as described. (2, 3 ) . In addition, colleagues in laboratories in Spain had received Greiner Vacuette product information with universal 48-h stability claims (4 ) . Data supporting the claims described above were not provided in any of the above instances and could not be found during an extensive literature search.
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The 48-h stability claim is presented in a way that may be interpreted by many users of this product as being generally applicable to all serum and plasma chemistry analytes without limitations. Although many commonly measured analytes are stable in serum or plasma up to 48 h, natural degradation and/or absorption of compounds by synthetic barriers, such as polymer separating gels, in tubes can occur. In one study, in three different blood collection tubes with inert barriers, phenobarbital and carbamazepine concentrations decreased significantly after 24 h (5 ). Another study found significant decreases of 5.9 -64.5% in phenytoin, phenobarbital, lidocaine, quinidine, and carbamazepine as a function of both time and sample volume when serum was stored in certain serum separator blood collection tubes (6 ) . These decreases were attributed to absorption of the drugs by the barrier gels. Several other studies have also highlighted the potential interference of separation gels with therapeutic drug monitoring (7) (8) (9) (10) (11) . In a report by Williams et al.
(12 ), serum alanine aminotransferase decreased 6% in separated serum stored 2 days at 4°C and 20% at 22°C. Storage of blood in plasma separator tubes overnight can cause differences in urate concentration that are likely to affect clinical interpretation (13 ).
Several European experts in clinical chemistry and the NCCLS have published specimen handling recommendations to reduce preanalytical variables (14 -16 ). These recommendations differ considerably from the ones made by Greiner regarding storage of their products (1-3 ) . The degradation of certain chemistry analytes or their absorption by tube components can be a significant source of error in the preanalytical phase of laboratory testing. Greiner's claim of universal 48-h stability appears to be incompatible with the experience described in the literature and currently recommended laboratory standards. Hospital and reference laboratories that rely on the claim and store specimens for 48 h may be unaware of the potential effects of the preanalytical phase of testing.
Blood collection devices and their proper handling play an integral part in routine laboratory analyses. Technical improvements that have been made to these devices in the past (e.g., separating gel) have generally led to a reduction of preanalytical variability and an improved quality of the overall testing process. New claims made by tube manufacturers to further improve their products should therefore be supported by the
